We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-25.76%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.84B
AUM Growth
-$1.24B
Cap. Flow
-$319M
Cap. Flow %
-17.29%
Top 10 Hldgs %
78.72%
Holding
62
New
2
Increased
–
Reduced
2
Closed
7

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$27.6M
2
VLD
Velo3D, Inc.
VLD
+$17.9M

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$280M
2
RCUS icon
Arcus Biosciences
RCUS
+$80.9M
3
DXCM icon
DexCom
DXCM
+$1.3M
4
TWLO icon
Twilio
TWLO
+$611K
5
NXDR
Nextdoor Holdings
NXDR
+$583K

Sector Composition

Rank Sector Weight
1 Healthcare 57.09%
2 Technology 28.81%
3 Industrials 9.28%
4 Consumer Staples 2.28%
5 Financials 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VLD
26
DELISTED
Velo3D, Inc.
VLD
$7.4M 0.4%
+153,191
New +$17.9M
RANI icon
27
Rani Therapeutics
RANI
$95.6M
$7.38M 0.4%
714,471
– –
DBTX
28
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$6.89M 0.37%
1,636,258
– –
FHTX icon
29
Foghorn Therapeutics
FHTX
$285M
$6.81M 0.37%
500,901
– –
BRNS
30
Barinthus Biotherapeutics
BRNS
$24.6M
$6.74M 0.37%
1,513,644
– –
SNCE
31
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$6.45M 0.35%
160,363
-1,691
-1% -$124K
KRON
32
DELISTED
Kronos Bio
KRON
$5.24M 0.28%
1,438,232
– –
TNYA icon
33
Tenaya Therapeutics
TNYA
$168M
$5.16M 0.28%
915,705
– –
NEWR
34
DELISTED
New Relic, Inc.
NEWR
$4.56M 0.25%
91,132
– –
VERA icon
35
Vera Therapeutics
VERA
$2.54B
$4.11M 0.22%
301,580
– –
DNTH icon
36
Dianthus Therapeutics
DNTH
$5.68B
$4.01M 0.22%
208,696
– –
TCRX icon
37
TScan Therapeutics
TCRX
$51.9M
$3.39M 0.18%
1,077,080
– –
AMPL icon
38
Amplitude
AMPL
$1.07B
$2.71M 0.15%
189,447
– –
TSHA icon
39
Taysha Gene Therapies
TSHA
$1.59B
$2.38M 0.13%
640,882
– –
OMIC
40
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$2.24M 0.12%
19,553
– –
EVLO
41
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$2.24M 0.12%
53,025
– –
HYPR icon
42
Hyperfine
HYPR
$94.7M
$2M 0.11%
898,720
– –
AUTL
43
Autolus Therapeutics
AUTL
$386M
$1.98M 0.11%
698,262
– –
ALEC icon
44
Alector
ALEC
$164M
$1.79M 0.1%
175,866
– –
FULC icon
45
Fulcrum Therapeutics
FULC
$248M
$1.25M 0.07%
255,452
– –
ENJY
46
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$943K 0.05%
4,345,340
– –
EXAS
47
DELISTED
Exact Sciences
EXAS
$914K 0.05%
23,205
– –
OPRT icon
48
Oportun Financial
OPRT
$257M
$784K 0.04%
94,788
– –
SPRO icon
49
Spero Therapeutics
SPRO
$68.9M
$659K 0.04%
889,979
– –
NVTA
50
DELISTED
Invitae Corporation
NVTA
$527K 0.03%
215,965
– –
1
2
3

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q2 2022 Portfolio in Review

As of Q2 2022, Alphabet Inc held 62 positions worth $1.84B, down 40% from $3.08B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Alphabet Inc withdrew a net $319M in Q2 2022, closing 7 positions and reducing 2 holdings. Its most notable exit was IonQ, an estimated $280M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alphabet Inc opened a new position in GitLab worth $31.5M.

  • Alphabet Inc's largest Q2 2022 buy was GitLab: 593,404 shares worth $31.5M.
  • Alphabet Inc's biggest Q2 2022 reduction was DexCom, cutting an estimated $1.3M.
  • Alphabet Inc fully exited IonQ in Q2 2022, selling an estimated $280M.
  • Alphabet Inc's ten largest holdings make up 79% of its $1.84B portfolio in Q2 2022.
  • Alphabet Inc opened 2 new positions and closed 7 in Q2 2022.
  • Alphabet Inc's portfolio value fell 40% quarter-over-quarter to $1.84B.

Based on Alphabet Inc's 13F filing for Q2 2022, filed 15 Nov 2022.